Oxymorphone hydrochloride 5 MG Oral Tablet — RxCUI 977939
RxNorm drug concept · Semantic clinical drug
RxCUI 977939
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
19 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI977939
Official nameOxymorphone hydrochloride 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asoxyMORphone HCl 5 MG Oral Tablet
FDA products mapped13
Package NDCs mapped19
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Oxymorphone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The regular oxymorphone tablet is meant for short-term, acute pain — the kind that hits hard and needs quick relief for a limited time. You'd take it every four to six hours as nee...
- What's the difference between the regular tablet and the extended-release tablet?
- It's a real safety point, not just a suggestion. Eating a meal before taking oxymorphone — especially the extended-release version — can raise the amount of drug that gets into you...
- Why does my pharmacist keep telling me to take this on an empty stomach?
🕸️ Concept Web — How Oxymorphone hydrochloride 5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Oxymorphone hydrochloride 5 MG Oral Tablet
RxCUI 977939 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Oxymorphone
7814IN -
Oxymorphone hydrochloride
82064PIN
-
Oxymorphone
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Oxymorphone Oral Tablet
643113SCDF -
Oxymorphone hydrochloride Oral Tablet
2645490SCDFP -
Oxymorphone Oral Product
1162252SCDG -
Oxymorphone Pill
1162253SCDG -
Oxymorphone hydrochloride Oral Product
2660073SCDGP -
Oxymorphone hydrochloride Pill
2659325SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Oxymorphone Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Oxymorphone hydrochloride 5 MG
977922SCDC
-
Oxymorphone hydrochloride 5 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Oxymorphone hydrochloride 5 MG
SCDC · 977922 -
Oxymorphone Oral Tablet
SCDF · 643113 -
Oxymorphone hydrochloride Oral Tablet
SCDFP · 2645490 -
Oxymorphone Oral Product
SCDG · 1162252 -
Oxymorphone Pill
SCDG · 1162253 -
Oxymorphone hydrochloride Oral Product
SCDGP · 2660073 -
Oxymorphone hydrochloride Pill
SCDGP · 2659325
📦 FDA Products & Package NDCs
13 products · 19 package NDCs
19 package NDCs map to RxCUI 977939 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0283-25 | 100 TABLET in 1 BOTTLE (0054-0283-25) | Oxymorphone Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2010-09-27 |
| 00054-0284-25 | 100 TABLET in 1 BOTTLE (0054-0284-25) | Oxymorphone Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2010-09-27 |
| 10702-0070-01 | 100 TABLET in 1 BOTTLE (10702-070-01) | Oxymorphone Hydrochloride | KVK-Tech, Inc. | 2013-02-11 |
| 10702-0070-06 | 60 TABLET in 1 BOTTLE (10702-070-06) | Oxymorphone Hydrochloride | KVK-Tech, Inc. | 2018-06-25 |
| 10702-0071-01 | 100 TABLET in 1 BOTTLE (10702-071-01) | Oxymorphone Hydrochloride | KVK-Tech, Inc. | 2013-02-11 |
| 10702-0071-06 | 60 TABLET in 1 BOTTLE (10702-071-06) | Oxymorphone Hydrochloride | KVK-Tech, Inc. | 2018-06-25 |
| 13107-0103-01 | 100 TABLET in 1 BOTTLE (13107-103-01) | Oxymorphone Hydrochloride | Aurolife Pharma, LLC | 2016-04-26 |
| 13107-0103-30 | 30 TABLET in 1 BOTTLE (13107-103-30) | Oxymorphone Hydrochloride | Aurolife Pharma, LLC | 2016-04-26 |
| 13107-0103-99 | 1000 TABLET in 1 BOTTLE (13107-103-99) | Oxymorphone Hydrochloride | Aurolife Pharma, LLC | 2016-04-26 |
| 13107-0104-01 | 100 TABLET in 1 BOTTLE (13107-104-01) | Oxymorphone Hydrochloride | Aurolife Pharma, LLC | 2016-04-26 |
| 13107-0104-30 | 30 TABLET in 1 BOTTLE (13107-104-30) | Oxymorphone Hydrochloride | Aurolife Pharma, LLC | 2016-04-26 |
| 13107-0104-99 | 1000 TABLET in 1 BOTTLE (13107-104-99) | Oxymorphone Hydrochloride | Aurolife Pharma, LLC | 2016-04-26 |
| 31722-0929-01 | 100 TABLET in 1 BOTTLE (31722-929-01) | OXYMORPHONE HYDROCHLORIDE | Camber Pharmaceuticals, Inc | 2018-03-01 |
| 31722-0930-01 | 100 TABLET in 1 BOTTLE (31722-930-01) | OXYMORPHONE HYDROCHLORIDE | Camber Pharmaceuticals, Inc | 2018-03-01 |
| 42806-0330-01 | 100 TABLET in 1 BOTTLE (42806-330-01) | Oxymorphone Hydrochloride | Epic Pharma, LLC | 2019-05-15 |
| 42806-0331-01 | 100 TABLET in 1 BOTTLE (42806-331-01) | Oxymorphone Hydrochloride | Epic Pharma, LLC | 2019-05-15 |
| 63629-1926-01 | 100 TABLET in 1 BOTTLE (63629-1926-1) | OXYMORPHONE HYDROCHLORIDE | Bryant Ranch Prepack | 2021-01-14 |
| 72865-0130-01 | 100 TABLET in 1 BOTTLE (72865-130-01) | OXYMORPHONE HYDROCHLORIDE | XLCare Pharmaceuticals, Inc. | 2020-05-06 |
| 72865-0131-01 | 100 TABLET in 1 BOTTLE (72865-131-01) | OXYMORPHONE HYDROCHLORIDE | XLCare Pharmaceuticals, Inc. | 2020-05-06 |
Observed labelers:
Aurolife Pharma, LLC (6) ·
KVK-Tech, Inc. (4) ·
Camber Pharmaceuticals, Inc (2) ·
Epic Pharma, LLC (2) ·
Hikma Pharmaceuticals USA Inc. (2) ·
XLCare Pharmaceuticals, Inc. (2)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.